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Abstract
Background: It is important that potential study participants are appropriately informed and understand what is
involved with their research participation. A few studies have examined study participants’ understanding of the
informed consent process and the adequacy of the information they received when agreeing to participate in a
randomised controlled trial. Deficiencies in the consent process have been found. This topic remains an under
researched area of acupuncture research. The aim of this study was to examine participants’ understanding of their
informed consent and the adequacy of the information presented when agreeing to participate in a randomised
controlled trial of acupuncture.
Methods: All women who participated in a randomised controlled trial over an 11 month period were invited
to participate in a survey. An anonymous self-completion questionnaire was designed and covered participants’
understanding of informed consent in the clinical trial, their views of the information provided, the opportunity
to ask questions, the use of sham acupuncture, their recall of study visits and processes for withdrawal, and their
reason for participating in the trial.
Results: A response rate of 59 % was obtained. Over 90 % of subjects indicated there was plenty of opportunity
to discuss the study prior to giving consent, and 89 % indicated that questions asked were answered to their satisfaction.
The majority of women indicated the amount of information describing acupuncture was about right, however 24 %
would have liked more. Information describing sham acupuncture was not considered adequate by 48 % of women,
and 35 % would have liked more information, 30 % could not recall why, or were uncertain why a sham group was
used. Participants indicated less understanding of the information relating to payment if they became ill due to study
participation, risks and discomforts from the study interventions, which of the procedures were experimental and for
how long they would be involved in the study.
Conclusion: Trial participants’ understanding of informed consent was overall satisfactory but highlighted some areas of
deficiency. Future studies could consider use of supplementary material such as Q and A fact sheets.
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Background
When study participants agree to participate in rando-
mised controlled trials (RCTs) there is no guarantee of a
direct benefit to the individual. Therefore it is important
that potential participants are fully informed about what is
involved with participating in the study and that they
understand the potential risks and benefits, and the pro-
cesses of a RCT. The process of obtaining consent should
ensure that the potential participants have been given
sufficient time to consider their participation, and the
opportunity to discuss the study with others prior to pro-
viding informed written consent. International guidelines,
regulatory requirements, and the Declaration of Helsinki
[1] describe this structure and process as the participant
information and consent form. These guidelines detail the
requirements of administering informed consent stressing
the participants’ understanding of the information and
their freedom to decide independently to participate in a
study. The following aspects have been identified as essen-
tial for informed consent competence disclosure, under-
standing, voluntariness and consent [2].
Many studies have examined study participants’ under-
standing of the informed consent process and the ad-
equacy of the information they received when considering
participation in a RCT. Deficiencies in the consent process
were common. Previous research reported by Brown and
colleagues found that half of study participants could not
recall facts about randomisation and the processes for
withdrawing from the study [3]. An Australian study of
oncology patients found 43 % correctly understood the
process of randomisation, they thought the allocation to a
group was made by chance, and 74 % agreed with the
statement in a clinical trial the doctor would make sure I
got the best of the treatments [4]. An Italian study examin-
ing informed consent reported 62 % understood the study
procedures and the nature of the trial [5].
The informed consent process has not been well studied
in relation to acupuncture studies. Hughes and colleagues
examined the consent process in a RCT of sham acupres-
sure which did not explicitly indicate that participants
may receive a sham intervention [6]. Participants in this
study indicated that they believed they were fully informed
when giving consent that it was acceptable to use a sham
intervention, and that the majority indicated they assumed
one of the treatment arms would be a placebo. In relation
to acupuncture this remains an under-researched area,
it is important to ensure that the conduct of acupunc-
ture research meets the requirements of ethically sound
research.
The ACU-ART RCT is a multi-centre randomised con-
trolled trial currently being implemented in Australia and
New Zealand and is examining the role of acupuncture as
an adjunct to in vitro fertilisation (IVF) to improve live
birth rates [7]. This trial is a parallel RCT of acupuncture
compared with a sham control using a non-invasive
placebo needle [8]. The placebo needle has a retractable
needle shaft, a blunt tip, and skin penetration does not
occur, and the needles have a supporting device. The loca-
tion of sham non-acupuncture points are away from real
points and are described in relation to anatomical land-
marks and relationship to acupuncture channels. The
study is co-ordinated centrally from Western Sydney
University Australia, and to date eighteen IVF units have
joined the multi-centre trial. We utilised a lead human
research ethics committee (HREC) patient information
consent form which covered nine recruitment sites, and is
comprised of three pages. Separate information and con-
sent forms have been approved by other site specific
HREC requirements, and the quantity of information pre-
sented varies over three to eight pages. The participant in-
formation form describes the rationale for the study,
explains to participants that they may be randomised to
one of two groups, acupuncture or sham control, the
potential risks and benefits including highlighting the risk
of side effects from treatment. Research nurses are
responsible for providing information to women, and fol-
low up to obtain informed consent. The trial co-ordinator
with a background in acupuncture and research methods
is available to provide additional information on the study
to study participants, with a subsequent conversation by
phone or email following randomisation to the trial. This
usually provides an opportunity for women to ask and to
have answered additional questions about the study or
acupuncture if these were not addressed by the research
nurse. Study participants, reproductive medicine health
care providers, the outcome assessors, and the analyst are
blind to study group allocation. The aim of this side study
was to examine participants’ understanding of their in-
formed consent and the adequacy of the information pre-
sented particularly relating to randomisation and blinding.
Methods
Women eligible to participate in the clinical trial are aged
less than 43 years undergoing a fresh IVF or intracytoplas-
mic sperm injection (ICSI) cycle, and not currently receiv-
ing acupuncture. Participants received an initial study
treatment between days 6–8 of their stimulated IVF cycle.
All women who were randomised to the ACU-ART trial
between December 2013 and November 2014 were invited
to participate in this study. An amendment was submitted
and approved from the University of Western Sydney
Human Ethics Committee (H8936) and nine collaborating
IVF unit Human Ethics Committees.
An anonymous self-completion questionnaire was de-
signed and covered different aspects of the informed con-
sent process and information relating to the participant
information sheet. We utilised some questions used in
previous studies [5, 9–11] despite these instruments not
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undergoing extensive validity and reliability testing. The
questionnaire used a combination of closed and open
questions. Closed questions included the subject’s reason
for participating in the trial, the opportunity to ask ques-
tions, awareness of the risks and side effects, the use of
sham acupuncture, their recall of the number of study visits
required, the process of withdrawing from the trial, and
demographic questions including age, place of residence
and education. Questions examined opinions relating to
what their participation in the trial involved, and responses
to these questions were scored along a five point Likert
scale ranging from one- I didn’t understand at all, to five- I
understood very well. Open questions examined partici-
pants’ understanding and recall of terms such as random-
isation and sham acupuncture (Copy of questionnaire see
Appendix 1). The questionnaire was sent by post or email
from the trial co-ordinator based at the University of
Western Sydney. Statistical analyses were carried out using
SPSS software (the IBM Statistical Package for the Social
Sciences 19, Chicago, IL). Descriptive statistics, using
frequencies and percentages were used to describe the data.
Results
A total of 353 questionnaires were sent out and responses
were received from 210 participants giving a response rate
of 59 %. Responses to the survey indicated representation
across Australian States and Territories, and from our
three overseas recruitment sites in New Zealand. The
majority of women completing the survey were aged over
35 years, and the majority were highly educated (Table 1).
All women indicated the primary reason for partici-
pating in the study was the they hoped acupuncture
would improve their chance of having a baby. In
addition 61 women (29 %) indicated the importance
of undertaking research as a key reason for joining
the trial. We sought women’s views about the infor-
mation they received and the opportunity to ask
questions when considering their involvement in the
study (Table 2). Over 90 % indicated there was
enough opportunity to discuss the study with the
clinical staff before deciding to join the trial, and
89 % indicated that any questions they asked were
answered to their satisfaction. The majority of women
indicated the information describing acupuncture was
about right, however 48 (24 %) would have liked
more (Table 2). Information describing sham acu-
puncture was not considered adequate by approxi-
mately half of the women, and 35 % would have liked
more information. The role of educational status was
examined in response these questions and we found
women with tertiary education would have liked more
information on acupuncture (p < 0.009), no other
associations were found.
Table 1 Demographic characteristics of study participants
Demographics Survey population




Missing data 14 6.6
Place of residence
New Zealand 69 32.8
South Australia 45 21.4
New South Wales 40 19.0
Victoria 36 17.1




Did not finish high school 9 4.2
High School Certificate 22 10.4
Vocational training 42 20.0
University degree 121 57.6
Missing 16 7.6
Table 2 Views of information presented on the study
Participation in the trial N = 210 %
Opportunity to ask question
Yes plenty of time 191 91.0
No little opportunity 11 5.2
I can’t remember 8 3.8
Questions answered to your satisfaction
Yes completely 140 66.7
Yes mainly 49 23.3
No I wasn’t happy with the answers 1 0.5
I didn’t ask any questions 17 8.1
I can’t remember 3 3.8
Information on acupuncture (n = 198)
It was about right 142 71.7
I would have liked more 48 24.2
Information too detailed 4 2.0
I can’t remember 4 2.0
Information on sham acupuncture (n = 198)
It was about right 104 52.5
I would have liked more 70 35.4
I can’t remember 20 10.1
Information too detailed 4 2.0
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Understanding of the patient information
We asked about participants’ understanding of the
study based upon the written information they received
and follow up verbal interaction with study staff
(Table 3 Appendix 1, question 5). The majority of par-
ticipants clearly understood what the study involved
with overall mean scores of 4 in response to these
questions. There were five areas in which participants
indicated less understanding, these related to payment
if they became ill due to their participation in the study,
risks and discomforts from the study interventions,
which of the procedures were experimental and for
how long they would be involved in the study. In
addition, over 75 % recalled they were required to at-
tend for treatment on two occasions, and 50 % could
accurately recall when they were required to complete
questionnaires.
We explored participants’ understanding of selected
areas relating to questions about the trial and the research
terminology used in the patient information sheets
through open-ended questions. Participant responses indi-
cated some deficiencies. Over 82 % of responses indicated
women could recall what a RCT meant. Responses were
illustrated by the following quotations “I will be selected at
random to be in the real or sham acupuncture group to
assess the effect of acupuncture on live birth rates”. Many
participants responded indicating their understanding of
randomisation and blinding, for example, “that the person
is randomly picked to be in the sham or real acupuncture
group”, “I will be allocated to either a treatment or a
control group, blind study means I won’t be aware of which
group I was allocated to”. Some subjects responded by
discussing the randomisation process, “its like a name in a
hat you get randomly drawn to have either real or placebo
acupuncture”, and “ where a computer randomly selects
which group you will be in”. Incorrect responses reflected
responses relating to blinding “ no one knows which group
you are in”, participants receive either sham or actual
treatment without knowing which one”, or general re-
sponses relating to the purpose of the study “its a experi-
ment used to test the effectiveness of something in this case
the acupuncture meridians on the pregnancy success rates
in IVF patients”.
We asked why was sham acupuncture used? Thirty
percent could not recall why or were uncertain, and
69 % provided an explanation. Many described it in
terms of a non-specific effect relating it to the placebo
effect, “because it was the placebo treatment, you need to
see whether the outcomes would be affected by receiving
acupuncture or not”, “to rule out the placebo effect, or to
rule it in”, “to see if it is all in the mind”. Others indi-
cated their understanding of the use of a control group,
“ to determine if real acupuncture does actually cause
more pregnancies”, “as a control group to eliminate
changes caused by bias or belief”, “to see if specific points
had results that can be compared against the sham
results”. “Sham acupuncture is used to control for the
physiological and psychological effects”.
Fifty nine percent of participants indicated they could
not recall the process to withdraw from the study with an
additional 16 % responding they were unclear. Of those
indicating they understood the process for withdrawing, a
small number mentioned they could withdraw any time,
however the majority of participants responded to this
question by explaining they were of aware of the process
to contact the site research nurse or the trial co-ordinator
to communicate their intention to withdraw.
Recall of the potential risks and side effects was poor.
Over 41 % could not describe any side effects or risks and
a further 29 % were unsure. Twenty eight percent of
women listed side effects, with the majority accurately
recalling acupuncture side effects listed on the informa-
tion sheet including slight discomfort, pain from needling,
and the less frequently occurring events relation to feeling
lighted heads, nausea, and dizziness. Five inaccurately
recalled a risk of infection.
Discussion
Our results indicate that trial participants’ understanding of
informed consent was overall satisfactory but highlighted
some areas where our expectations were not met. Womens’
primary motivation for deciding to join the study was for
the potential benefit of improving their chances of success
from their IVF cycle although the importance of undertak-
ing the research was additionally highlighted by many
women. Overall their understanding of aspects about their
trial participation was high, although five areas were
highlighted as areas of concern.
Table 3 Participants understanding of the study
n = 199 Mean SD
The fact that participation is voluntary 4.6 1.0
That your treatment involved research 4.5 1.0
What the researchers were trying to find out 4.3 1.0
Treatments and procedures you would undergo 4.3 1.0
How your participation may benefit future patients 4.3 1.0
Possible benefits from participating in the trial 4.2 1.1
Overall how well you understood the study when
you signed the consent form
4.2 1.0
Who to contact if you have questions 4.3 1.1
Possible trial risks and discomforts 3.8 1.2
How long you would be in the trial 3.8 1.1
Which treatments were experimental 3.7 1.2
Alternatives to participation in the trial 3.6 1.4
Who will pay for treatment if you become ill/injured 3.0 1.5
Smith and Fogarty BMC Complementary and Alternative Medicine  (2016) 16:10 Page 4 of 6
Participants felt they had the opportunity to ask ques-
tions and generally these were met to women’s satisfac-
tion. Women’s understanding of why sham acupuncture
was used was satisfactory however many women would
have liked additional information on both acupuncture
and sham acupuncture beyond that provided in the
participant information form. Further questioning also
confirmed a lack of understanding, or recall about
potential side effects that could arise, and the processes
for withdrawing from the trial. The terms randomisation
and blinding appear to be well understood. The variation
of women’s response to this question however reflects
the individual’s experiences and their responses to this
standardised process.
Our findings indicate high levels of research literacy
regarding terminology which could have been influenced
by the fact that many of our participants had a tertiary
education, and perhaps may be more familiar with some
of the research terminology frequently used. Responses
to those questions indicating a lack of understanding may
be attributed to observations that written information is
in fact not well read by some participants, or is only
partially understood. Information on this trial is generally
presented at the start of an IVF cycle, which coincides
with a significant amount of complex information being
presented to patients in relation to their medical treat-
ment. This may have influenced women’s comprehension
and capacity to retain or recall information that was pre-
sented to them about the trial. Despite the potential for an
overload of information being presented we found there
was high satisfaction with women’s questions being well
answered by the trial co-ordinator or research nurses.
However, our findings indicate there were some areas that
could be re-enforced in subsequent conversations or with
the provision of additional supplementary material, this is
important to ensure that the trial is being conducted in a
sound ethical manner.
Our findings concur with some authors and differ to
others. Studies have frequently reported that participants
have a poor understanding of research side effects, and
other trial processes [5, 12, 13]. However contrary to
other studies [14, 15] we found that our participants had
a good understanding of randomisation. This may be
explained by the relatively higher education attributes of
our study population. Participants vary in their informa-
tion needs, and this has been explored and tested in a
simple intervention by Kass et al. to improve informed
consent [16]. Their study demonstrated that bulleted fact
sheets and a Q and A session demonstrated a greater
understanding than the standard process of a written pa-
tient information form. These communication formats
are more desirable rather that adding more information
to standard participant information and consent forms
which are already long, and can vary in their format and
the identification of information that is most important.
Nishimura and colleagues in their systematic review
identified use of enhanced consent forms, and extended
discussion led to improved knowledge outcomes, and
that multi-media interventions may prove most useful
with long term retention of study information [17].
There are several limitations to the study. The time
between the trial participation and questionnaire was up to
six months for some study participants and recall bias
could have been significant for some of these women.
Participants’ self-rated their understanding of the trial
processes, there is a possibility of responder bias. The
inclusion of additional follow up questions for some key
areas however allowed us to objectively confirm the partic-
ipants’ understanding. Our response rate was 59 %, with
41 % choosing not to participate, there maybe selection
bias. It is possible that women responding to this survey
were self-selected based upon their interest in this side
study, had a greater understanding and recall of the
processes involved with the study. Non responders may
have lost interest with participating in the study due to a
negative pregnancy outcome. This non response bias may
result in our findings being an over-estimate of the study
outcome participant’s understanding of the informed con-
sent process. The survey was anonymous and we are un-
able to compare the socio-demographics of responders
and non responders to determine whether this influenced
study participation . Although we utilised several questions
from previous studies [5, 9, 10, 12] not all questions have
established validity and reliability. The survey comprised of
mostly closed questionnaires with a limited number of
open ended questions. This limited the opportunity to
examine participants’ understanding of the informed con-
sent process in detail. Future research could consider the
use of a qualitative study. We also had variable responses
to questions with missing data. Participants may have ran-
domly forgotten to complete a question, or they may have
refused to answer, this may influence the reliability of our
findings. We propose the sample is demographically repre-
sentative of women undertaking IVF. We found that the
age of women participating in our study is similar to
women undergoing IVF in Australia and New Zealand
(<35 years 35 % vs 37 %, 35–44 years 57% vs 60 %). We do
not have socio-demographic data from non-responders to
our survey due to the anonymous nature of the question-
naire, however we found that the higher educational
qualifications of women who participated in this side
study compared with the trial as a whole were similar
(University educated 57 % vs. 57 %, vocational training
20 % vs. 25 %), although there was a greater disparity
between those reported not completing high school
(4.2 % vs. 9 %). On the basis of these data we propose
that the findings reflect the broader population of
women undergoing ART.
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The language used in the participant information and
consent form seems acceptable and we do not have con-
cerns about scientific literacy in relation to the scientific
terms used and how they were explained. Our results do
highlight an opportunity to consider how to provide
additional information in future studies, and that a feasible
strategy could take the form of supplementary material
such as Q and A sheets that are made available to trial
participants at no significant cost to the researchers or the
clinical setting. This approach could be explored with
human ethics committees and researchers.
Conclusion
We have no concerns that informed consent has been
seriously compromised in this study, or that this study
was not ethically sound. Overall our findings suggest the
need for written information to go beyond explaining
the mechanisms of the trial, and highlight a need for
explaining how and why things are done, this can be ad-
dressed by having additional Q and A fact sheets.
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